logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Factor Bioscience Inc.


USPTO Granted Patents = 64


Trademarks = 7

Forward Citations = 502

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Matthew Angel (64 out of 67 patents)

silverMedal Christopher Rohde (64 out of 110 patents)

bronzeMedal Franklin Kostas (9 out of 9 patents)

4.  Mitchell Kopacz (1 out of 1 patent)


Core Competencies:
Transfection
Cationic Lipids
Nucleic Acid Delivery
Protein Expression
Cell Reprogramming
Gene Therapy
Nucleic Acid Production
Transfection Methods

64 patents:

1. 12735687 - ENGINEERED GENE-EDITING PROTEINS (2026-09-15),
2. 12559772 - METHODS AND PRODUCTS FOR TRANSFECTING CELLS (2026-02-24),
3. 12391961 - Methods and products for transfecting cells (2025-08-19),
4. 12384740 - Cationic lipids and transfection methods (2025-08-12),
5. 12344572 - Cationic lipids and transfection methods (2025-07-01),
6. 12227768 - Methods and products for transfection (2025-02-18),
7. 12227757 - Methods and products for transfecting cells (2025-02-18),
8. 12201675 - Methods and products for nucleic acid production and delivery (2025-01-21),
9. 12006508 - Methods and products for expressing proteins in cells (2024-06-11),
10. 11904023 - Nucleic acid products and methods of administration thereof (2024-02-20),
11. 11814333 - Cationic lipids and transfection methods (2023-11-14),
12. 11708586 - Methods and products for transfecting cells (2023-07-25),
13. 11692203 - Methods and products for transfecting cells (2023-07-04),
14. 11492600 - Methods and products for transfection (2022-11-08),
15. 11466293 - Methods and products for transfecting cells (2022-10-11),
Company Overview
Factor Bioscience Inc., based in Cambridge, MA, specializes in advanced cell transfection technologies. The company focuses on the development of innovative solutions for nucleic acid delivery, utilizing cationic lipids to enhance protein expression and facilitate gene therapy applications. Their expertise extends to cell reprogramming and nucleic acid production, positioning them at the forefront of biotechnological advancements aimed at improving therapeutic outcomes. Factor Bioscience is dedicated to transforming the landscape of genetic research and therapeutic development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

64 Patents

#43 in Cambridge, MA

#321 in Massachusetts

#5,679 in US

#11,465 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Factor Bioscience Inc.

Forward Citations = 502

4 inventors:

goldMedal Matthew Angel (64 out of 67 patents)

silverMedal Christopher Rohde (64 out of 110 patents)

bronzeMedal Franklin Kostas (9 out of 9 patents)

4.  Mitchell Kopacz (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Factor Bioscience Inc.. Retrieved from https://idiyas.com/company/factor-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…